CN Stock MarketDetailed Quotes
002872 Tiansheng Pharmaceutical Group
- 4.95
- +0.10+2.06%
Not Open Dec 12 15:00 CST
1.57BMarket Cap-33.00P/E (TTM)
4.96High4.84Low39.31KlotVolume4.84Open4.85Pre Close19.24MTurnover1.83%Turnover RatioLossP/E (Static)318.00MShares5.9752wk High0.77P/B1.06BFloat Cap3.1752wk Low5.09Limit Up214.92MShs Float35.02Historical High4.61Limit Down2.47%Amplitude3.17Historical Low--Dividend TTM4.90Avg Price15.42KlotAsk--Div YieldTTM100Lot Size23.81KlotBid
Tiansheng Pharmaceutical Group Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -0.99%402.36M | -4.06%281.42M | -5.98%147.99M | -4.56%579.33M | 0.41%406.39M | 8.50%293.33M | 16.29%157.41M | -17.61%606.99M | -32.75%404.75M | -45.38%270.35M |
| Operating revenue | -0.99%402.36M | -4.06%281.42M | -5.98%147.99M | -4.56%579.33M | 0.41%406.39M | 8.50%293.33M | 16.29%157.41M | -17.61%606.99M | -32.75%404.75M | -45.38%270.35M |
| Other operating revenue | ---- | -8.25%15.02M | ---- | 30.28%38.78M | ---- | 29.27%16.37M | ---- | 25.29%29.76M | ---- | 77.51%12.66M |
| Total operating cost | -7.94%461.24M | -8.63%324.66M | -6.63%173.32M | -5.18%675.59M | 2.40%501.01M | 9.27%355.34M | 17.40%185.62M | -12.43%712.46M | -29.52%489.26M | -41.31%325.2M |
| Operating cost | -0.56%221.6M | 1.44%154.64M | -3.41%80.69M | 16.30%306.57M | 24.43%222.84M | 32.18%152.44M | 60.82%83.54M | -39.08%263.59M | -51.61%179.09M | -63.91%115.33M |
| Operating tax surcharges | -12.93%9.25M | -6.98%6.48M | 19.95%2.61M | 24.25%14.52M | 31.60%10.62M | 19.87%6.97M | 17.84%2.17M | 3.19%11.68M | -1.05%8.07M | 15.18%5.81M |
| Operating expense | -18.72%113.21M | -25.12%82.61M | -15.11%49.16M | -32.50%180.28M | -16.91%139.29M | 0.23%110.32M | 1.05%57.92M | 16.92%267.08M | -17.77%167.63M | -29.68%110.07M |
| Administration expense | -10.59%90.01M | -7.05%61.99M | 5.05%33.48M | 7.11%136.63M | -6.03%100.68M | -10.73%66.69M | -11.93%31.87M | 23.97%127.56M | 23.24%107.13M | 22.37%74.71M |
| Financial expense | 11.27%6.11M | 10.80%3.81M | -14.55%1.59M | -19.22%6.69M | -13.07%5.5M | -34.27%3.44M | -47.29%1.86M | -7.99%8.28M | 89.00%6.32M | 606.37%5.23M |
| -Interest expense (Financial expense) | 2.95%12.09M | 8.37%7.84M | -7.41%3.35M | -5.01%14.99M | -1.34%11.75M | -6.85%7.24M | -6.53%3.61M | -35.20%15.78M | -39.93%11.91M | -48.98%7.77M |
| -Interest Income (Financial expense) | 4.44%-5.98M | -6.48%-4.07M | 1.35%-1.76M | -11.70%-8.4M | -11.60%-6.25M | -49.20%-3.82M | -516.29%-1.78M | 55.36%-7.52M | 67.56%-5.6M | 84.97%-2.56M |
| Research and development | -4.68%21.05M | -2.25%15.13M | -30.01%5.78M | -9.79%30.92M | 5.05%22.09M | 10.15%15.48M | 13.25%8.26M | 17.19%34.27M | -3.53%21.03M | 9.15%14.05M |
| Credit Impairment Loss | 36.12%-4.29M | 2.65%-6.52M | -203.28%-1.33M | 18.01%-8.83M | 11.79%-6.72M | 22.97%-6.7M | 116.53%1.29M | 39.97%-10.76M | 31.24%-7.62M | 31.80%-8.69M |
| Asset Impairment Loss | -69.33%-4.23M | -65.39%-3.94M | -96.28%-209.44K | -0.19%-15.73M | -32.27%-2.5M | -15.90%-2.38M | ---106.7K | -50.03%-15.7M | 73.84%-1.89M | 71.53%-2.06M |
| Other net revenue | 93.54%20.19M | -154.04%-3.71M | -82.62%2.16M | -87.07%2.69M | -40.59%10.43M | 55.65%6.86M | 148.60%12.44M | 30.49%20.77M | -15.01%17.56M | -71.62%4.41M |
| Fair value change income | 189.36%816K | 1,466.67%564K | 314.29%348K | 271.88%330K | 267.86%282K | 140.00%36K | 7.69%84K | 50.77%-192K | 56.25%-168K | 70.59%-90K |
| Invest income | 82,996.89%16.17M | -360.49%-1.49M | 33.85%35.59K | -67.12%1.68M | -100.30%-19.5K | -28.92%571.24K | -95.13%26.59K | 3.07%5.11M | -10.04%6.43M | -89.52%803.7K |
| -Including: Investment income associates | -333.24%-3.55M | -2,265.72%-1.66M | 33.85%35.59K | -53.62%1.32M | ---818.87K | ---70.22K | --26.59K | 117.10%2.84M | ---- | ---- |
| Asset deal income | -99.66%6.33K | -99.72%4.95K | --6.15K | -97.55%233.89K | -77.77%1.86M | -74.03%1.78M | ---- | 82.54%9.53M | -4.58%8.37M | -2.87%6.84M |
| Other revenue | -33.09%11.73M | -43.40%7.67M | -70.32%3.31M | -23.75%25M | 40.93%17.53M | 78.28%13.56M | 109.65%11.15M | -5.03%32.79M | -46.92%12.44M | -63.95%7.61M |
| Operating profit | 54.03%-38.69M | 14.88%-46.94M | -46.91%-23.17M | -10.47%-93.57M | -25.74%-84.18M | -9.34%-55.15M | 11.18%-15.77M | -38.88%-84.71M | 6.55%-66.95M | -15.91%-50.44M |
| Add:Non operating Income | -44.58%686.77K | -71.59%349.19K | 29.91%193.12K | -64.52%923.34K | 164.56%1.24M | 262.05%1.23M | 168.13%148.66K | -88.62%2.6M | -88.34%468.4K | -78.59%339.46K |
| Less:Non operating expense | -83.49%885.42K | -19.36%398.62K | -53.03%249.52K | 3.04%2.07M | 410.61%5.36M | -43.11%494.31K | 394.85%531.24K | -87.67%2.01M | -71.73%1.05M | -47.29%868.9K |
| Total profit | 55.95%-38.89M | 13.64%-46.99M | -43.78%-23.22M | -12.61%-94.72M | -30.76%-88.3M | -6.77%-54.42M | 9.29%-16.15M | -54.50%-84.12M | 5.34%-67.53M | -16.96%-50.97M |
| Less:Income tax cost | 70.33%-1.81M | -3.52%-3.44M | -1,078.60%-2.49M | -113.59%-1.01M | -47.66%-6.11M | 15.69%-3.32M | 87.56%-211.47K | -58.44%7.44M | -39.58%-4.14M | -50.33%-3.94M |
| Net profit | 54.89%-37.08M | 14.76%-43.56M | -30.05%-20.73M | -2.36%-93.71M | -29.66%-82.19M | -8.64%-51.1M | 1.03%-15.94M | -26.56%-91.55M | 7.29%-63.39M | -14.82%-47.03M |
| Net profit from continuing operation | 55.19%-37.08M | 14.76%-43.56M | -30.05%-20.73M | -2.86%-94.27M | -30.40%-82.76M | -8.48%-51.1M | 1.03%-15.94M | -175.47%-91.65M | -1.77%-63.47M | -34.80%-47.1M |
| Net income from discontinuing operating | ---- | ---- | ---- | 488.94%561.49K | 672.48%561.49K | ---- | ---- | 100.24%95.34K | 101.21%72.69K | 101.21%72.69K |
| Less:Minority Profit | -97.27%-729.08K | -42.95%-449.63K | -447.70%-269.99K | 35.46%-638.84K | 54.41%-369.58K | 41.68%-314.54K | 85.93%-49.3K | 78.17%-989.82K | -49.95%-810.72K | -12.35%-539.37K |
| Net profit of parent company owners | 55.57%-36.35M | 15.11%-43.11M | -28.76%-20.46M | -2.77%-93.07M | -30.75%-81.83M | -9.23%-50.78M | -0.86%-15.89M | -33.56%-90.56M | 7.75%-62.58M | -14.85%-46.49M |
| Earning per share | ||||||||||
| Basic earning per share | 55.58%-0.1143 | 15.09%-0.1356 | -28.60%-0.0643 | -2.77%-0.2927 | -30.74%-0.2573 | -9.23%-0.1597 | -1.01%-0.05 | -33.58%-0.2848 | 7.74%-0.1968 | -14.85%-0.1462 |
| Diluted earning per share | 55.58%-0.1143 | 15.09%-0.1356 | -28.60%-0.0643 | -2.77%-0.2927 | -30.74%-0.2573 | -9.23%-0.1597 | -1.01%-0.05 | -33.58%-0.2848 | 7.74%-0.1968 | -14.85%-0.1462 |
| Other composite income | -67.52%-382.23K | -128.52%-228.17K | ||||||||
| Other composite income of parent company owners | ---- | ---- | ---- | -67.52%-382.23K | ---- | ---- | ---- | -128.52%-228.17K | ---- | ---- |
| Total composite income | 54.89%-37.08M | 14.76%-43.56M | -30.05%-20.73M | -2.52%-94.09M | -29.66%-82.19M | -8.64%-51.1M | 1.03%-15.94M | -28.30%-91.78M | 7.29%-63.39M | -14.82%-47.03M |
| Total composite income of parent company owners | 55.57%-36.35M | 15.11%-43.11M | -28.76%-20.46M | -2.93%-93.46M | -30.75%-81.83M | -9.23%-50.78M | -0.86%-15.89M | -35.50%-90.79M | 7.75%-62.58M | -14.85%-46.49M |
| Total composite income of minority owners | -97.27%-729.08K | -42.95%-449.63K | -447.70%-269.99K | 35.46%-638.84K | 54.41%-369.58K | 41.68%-314.54K | 85.93%-49.3K | 78.17%-989.82K | -49.95%-810.72K | -12.35%-539.37K |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Beijing Xinghua Certified Public Accountants Firm (Special General Partnership) | -- | -- | -- | Beijing Xinghua Certified Public Accountants Firm (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
